Sedentary Postmenopausal Women With Nonalcoholic Fatty Liver Disease (NAFLD) Submitted to Physical Activity
Anthropometric Evaluation and Body Composition in Sedentary Postmenopausal Women With Nonalcoholic Fatty Liver Disease (NAFLD) Submitted to Physical Activity
1 other identifier
interventional
40
1 country
1
Brief Summary
Were included 40 patients with NAFLD followed at the Ambulatory of Non-alcoholic Fatty Liver Disease , Discipline of Clinical Gastroenterology, Clinic Hospital of the Medical School of the University of Sao Paulo (HC-FMUSP). Were included adults women of any race, aged 35 to 75 years, diagnosed with NAFLD and were followed for a period of six months. All patients underwent anthropometric and body composition, as well as analysis of clinical, laboratory before and after 6 months of exercise training protocol established. The hypothesis of our research is that aerobic activity had a favorable impact on NAFLD. It is expected that the intervention of physical activity causes a decrease or no weight, decreased levels of aminotransferases, decreased insulin resistance assessed by homeostasis model assessment (HOMA) index and consequently decrease or reversal of hepatic steatosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2013
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
March 4, 2015
CompletedFirst Posted
Study publicly available on registry
April 27, 2015
CompletedApril 27, 2015
April 1, 2015
1.9 years
March 4, 2015
April 24, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Efficacy in reduce inflammatory component of NASH for transient elastography liver
Determine the efficacy of the physical activity in reducing the systemic inflammatory component of NASH in patients with NAFLD for transient elastography liver, FibroScan (FS) \[stiffness liver (SL) /CAP\]
6 months
Secondary Outcomes (1)
Inflammatory systemic profile
6 months
Study Arms (2)
Continuous Aerobic training
ACTIVE COMPARATORAerobic training continuous (n=19 patients) carry a protocol continuous aerobic training twice a week for 24 weeks and the session will last 60 minutes/2 days/week with recommendation for healthy diet.
Healthy diet
ACTIVE COMPARATORDiet group (n=21 patients) only recommendation for healthy diet.
Interventions
Supervised aerobic exercise program of 60 min/2 days/week at 60-85% of heart rate reserve for 24 weeks and healthy diet
Diet group (21) Recommendation for healthy diet.
Eligibility Criteria
You may qualify if:
- years of age, Female
- Biopsy-liver until 24 months previous that prove NAFLD or NASH
- Patients who agree to participate in the study and all signed informed consent.
You may not qualify if:
- Presence of alcoholism \<20g (women) of ethanol/day, drugs, schistosomiasis, hepatitis B or C and other chronic liver diseases cause determined
- Without medical clearance for physical activity
- Without availability to attend appointments and physical activities 2x/week
- Significant change in dietary habits and/or exercise in the last 3 months that resulted in weight loss \> 5%.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Sao Paulo School of Medicine
São Paulo, São Paulo, 01246903, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
CLAUDIA PM MD OLIVEIRA, PhD
University of Sao Paulo, School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
March 4, 2015
First Posted
April 27, 2015
Study Start
January 1, 2013
Primary Completion
December 1, 2014
Study Completion
December 1, 2014
Last Updated
April 27, 2015
Record last verified: 2015-04